A Synthetic Nanotube Antibody for Selective Molecular Recognition
Technology applications:
- In vivo or in vitro sensors for biological detection
- Targeted carbon nanotubes for therapeutic applications
Researchers
-
polymer-nanostructure composition for selective molecular recognition
United States of America | Granted | 9,664,677 -
polymer-nanostructure composition for selective molecular recognition
United States of America | Granted | 11,255,848
Technology
Molecular recognition and signal transduction are two central aspects and challenges to the design of sensor platforms. Natural antibodies are often used as vital components of sensors. However, antibodies are expensive, fragile and easily lose biological activity upon external treatment and exhibit batch-dependent variation, limiting their use. Moreover, certain biological molecules of interest don’t have a naturally existing antibody, including toxins, drugs and explosives. This has driven the search for methods to synthesize artificial antibodies from polymeric materials. SWNT photoluminescence (PL) has been used in sensor platforms for detection of DNA, divalent metal cations, genotoxins, reactive oxygen species and pH, among others. Yet, identifying methods to modulate SWNT PL in response to a specific analyte binding event remains a main challenge in sensor fabrication. Here, it is shown that a random polymer, with little or no affinity for an analyte, will adsorb in specific configurations to SWNTs such that the analyte will both bind to the polymer-SWNT complex and induce a measurable PL signal change. The polymer-nanotube complex can in effect act as a novel nanotube "sensor antibody".
Problem Addressed
This method provides a solution to developing "synthetic antibodies" from synthetic polymers adhered to single walled carbon nanotube surfaces.
Advantages
- For target protein or protein therapeutic detection there is no need to tag or label the target to enable detection as the SWNT complex binds directly
- Works for small molecules and molecules with no known binding partner
- Allows for continuous detection of the target analyte
- Multivalent interactions between the polymer and the SWNT are possible ensuring higher efficacy
- "Synthetic antibodies" may reduce development time compared to antibodies
- Can also be used to deliver therapeutic molecules, ensuring directed drug release
- Elucidation of in vivo reaction pathway because fluorescence is tissue transparent
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.